Product image of Lanolept (Clozapine) supplied by GNH India

Lanolept

Active Ingredient:
Clozapine
Origin:
EU

Lanolept (Clozapine)

Clozapine, the active ingredient in Lanolept, is an atypical antipsychotic presented as an oral formulation for oral use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adult patients requiring management of psychotic symptoms. The product is marketed in the European Union and complies with EU regulatory standards.

GNH India supplies Lanolept as a licensed, GDP‑compliant international pharmaceutical supplier, providing the medication to hospitals, pharmacies and clinics across global markets while adhering to stringent quality and safety protocols.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Clozapine is an atypical antipsychotic used in the management of psychotic disorders.
  • Schizophrenia: reduces positive and negative symptoms and improves overall functioning.
  • Schizoaffective disorder: stabilises mood disturbances and psychotic features.
  • Treatment‑resistant schizophrenia: provides therapeutic benefit when other antipsychotics have failed.

How It Works

  • Clozapine antagonises dopamine D2 receptors and serotonin 5‑HT2A receptors while modulating activity at a range of other neurotransmitter sites, including adrenergic, histaminergic and muscarinic receptors. This receptor profile leads to reduced dopaminergic transmission in mesolimbic pathways and enhanced serotonergic activity, contributing to its antipsychotic efficacy and distinctive clinical effects.

Side Effects

Clozapine may cause a variety of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Sedation or drowsiness
  • Weight gain
  • Excessive salivation (hypersalivation)
  • Constipation
  • Dizziness or orthostatic hypotension
  • Tachycardia

Serious or Rare Side Effects

  • Agranulocytosis (dangerously low white‑blood‑cell count)
  • Myocarditis or cardiomyopathy
  • Seizures, especially at higher plasma levels
  • Neuroleptic malignant syndrome
  • Severe orthostatic hypotension leading to fainting
  • Pulmonary embolism or deep‑vein thrombosis

Precautions & Warnings

  • Clozapine requires careful monitoring and patient education before and during therapy.
  • Monitor blood counts: perform regular complete blood count testing to detect agranulocytosis early.
  • Assess cardiac health: evaluate for myocarditis or cardiomyopathy, especially during initial weeks.
  • Evaluate metabolic parameters: monitor weight, glucose and lipid levels regularly.
  • Avoid abrupt discontinuation: taper the dose under medical supervision to reduce withdrawal risk.
  • Use caution in patients with seizure history: adjust dose and monitor closely.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Clozapine can interact with several medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

  • Concomitant use with other myelosuppressive agents (e.g., chemotherapy) may increase risk of severe neutropenia.
  • Strong CYP1A2 inhibitors such as fluvoxamine can raise clozapine plasma levels, heightening toxicity risk.

Moderate Interactions (Monitor Closely)

  • CYP1A2 inducers like smoking or carbamazepine may lower clozapine concentrations, reducing efficacy.
  • Concurrent CNS depressants (e.g., benzodiazepines, alcohol) can enhance sedation and respiratory depression.
  • Drugs that prolong QT interval (e.g., certain antiarrhythmics) may increase cardiac arrhythmia risk.

Frequently Asked Questions

Lanolept contains clozapine and is prescribed for the management of schizophrenia and schizoaffective disorder in adults. It is particularly useful in patients who have not responded adequately to other antipsychotic medications, helping to control both psychotic and mood symptoms.

Clozapine works by blocking dopamine D2 receptors and serotonin 5‑HT2A receptors while also influencing several other neurotransmitter systems. This combined antagonism reduces excessive dopamine activity in brain pathways linked to psychosis and modulates serotonin activity, contributing to its unique therapeutic profile.

The dose of Lanolept is individualized and set by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Dosage adjustments are made under medical supervision, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

The safety of clozapine in pregnancy and lactation has not been definitively established. It is classified as having an unknown pregnancy category, and potential risks to the fetus or infant should be weighed against the benefits of treatment. Consultation with a healthcare professional is essential before use.

To order Lanolept, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many second‑generation antipsychotics such as risperidone or olanzapine, clozapine has a broader receptor profile and is often effective in treatment‑resistant schizophrenia. However, it carries a higher risk of serious blood‑related side effects, requiring regular blood monitoring, which distinguishes it from other agents.

Lanolept should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight. Do not store in the bathroom or near heat sources, and ensure the container is tightly closed when not in use.

Lanolept is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. Patients should swallow the medication whole and avoid crushing or chewing unless specifically instructed, to maintain consistent absorption.

The most serious risks include agranulocytosis, a potentially life‑threatening drop in white‑blood‑cell count, myocarditis, seizures, and neuroleptic malignant syndrome. Regular blood monitoring and prompt reporting of symptoms such as fever, sore throat, chest pain, or unexplained weakness are essential for safety.

Lanolept should not be used by individuals with known hypersensitivity to clozapine or any of its excipients, patients with severe central nervous system depression, uncontrolled epilepsy, or those with a history of agranulocytosis. It is also contraindicated in patients with serious cardiac conditions without careful medical evaluation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clozapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT